Literature DB >> 10349800

Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women.

D A Magoffin1, S R Weitsman, S K Aagarwal, A J Jakimiuk.   

Abstract

OBJECTIVES AND
DESIGN: Leptin, a product of adipocytes, is a cytokine with multiple effects on the reproductive axis. Leptin causes the activation of STAT proteins within target cells. The aromatase gene promoter in adipose stromal cells contains a functional STAT binding region, leading to the hypothesis that leptin may regulate aromatase activity in fat tissue. To test this hypothesis, adipose stromal cells were isolated from subcutaneous abdominal fat or breast fat then placed into tissue culture.
MATERIALS AND METHODS: The cells were treated for three days with increasing concentrations of recombinant human leptin. Aromatase activity in the stromal cells was measured by the release of 3H2O from radiolabeled androstenedione precursor.
RESULTS: Basal aromatase activity varied markedly between, but there were no differences between abdominal fat and breast fat. Leptin concentrations in the physiological range of normal weight or thin women (10 ng/ml) had no effect on aromatase activity. In 2 of 8 abdominal fat cultures and 1 of 2 breast fat cultures, a high obese concentration of leptin (100 ng/ml) stimulated a significant increase in aromatase activity. In the remaining subjects there was no effect of leptin, even at high concentrations.
CONCLUSIONS: These data demonstrate that in approximately 30 percent of our subject population leptin was able to stimulate aromatase activity in adipose stromal cells at high concentrations. The elevated levels of aromatase activity may contribute to increase circulating estrogen levels in certain obese women and suggest that elevated leptin concentrations in obese women may cause locally elevated estrogen concentrations in the breast and thereby promote tumor formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349800

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  22 in total

1.  Effects of weight loss on leptin, sex hormones, and measures of adiposity in obese children.

Authors:  K M Sudi; S Gallistl; M H Borkenstein; D Payerl; R Aigner; R Möller; E Tafeit
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

2.  Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Carlo Floris; Daniela Massa; Giorgio Astara; Paola Chessa; Giovanni Mantovani
Journal:  J Mol Med (Berl)       Date:  2010-03-26       Impact factor: 4.599

Review 3.  Leptin--from regulation of fat metabolism to stimulation of breast cancer growth.

Authors:  Mariola Sulkowska; Jolanta Golaszewska; Andrzej Wincewicz; Mariusz Koda; Marek Baltaziak; Stanislaw Sulkowski
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

4.  Role of estrogen receptor signaling in skeletal response to leptin in female ob/ob mice.

Authors:  Russell T Turner; Kenneth A Philbrick; Amida F Kuah; Adam J Branscum; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2017-04-20       Impact factor: 4.286

5.  Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer.

Authors:  Amanda I Phipps; Diana S M Buist; Kathleen E Malone; William E Barlow; Peggy L Porter; Karla Kerlikowske; Ellen S O'Meara; Christopher I Li
Journal:  Ann Epidemiol       Date:  2012-02-25       Impact factor: 3.797

Review 6.  Role of Notch and its oncogenic signaling crosstalk in breast cancer.

Authors:  Shanchun Guo; Mingli Liu; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2010-12-28

7.  Plasma leptin levels and risk of breast cancer in premenopausal women.

Authors:  Holly R Harris; Shelley S Tworoger; Susan E Hankinson; Bernard A Rosner; Karin B Michels
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-16

Review 8.  The multifactorial role of leptin in driving the breast cancer microenvironment.

Authors:  Sebastiano Andò; Stefania Catalano
Journal:  Nat Rev Endocrinol       Date:  2011-11-15       Impact factor: 43.330

9.  Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women.

Authors:  Amanda I Phipps; Kathleen E Malone; Peggy L Porter; Janet R Daling; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-29       Impact factor: 4.254

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.